SALL4 Expression in Hepatocellular Carcinomas Is Associated with EpCAM-Positivity and a Poor Prognosis
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: There is increasing interest in hepatocellular carcinomas (HCC) expressing “stemness”-related markers, as they have been associated with aggressive behavior and poor prognosis. In this study, we investigated the usefulness of Sal-like protein 4 (SALL4), a recently proposed candidate marker of “stemness.” Methods: Immunohistochemical stains were performed for SALL4, K19, and epithelial cellular adhesion molecule (EpCAM) on tissue microarrays constructed from 190 surgically resected HCCs, and the results were correlated with the clinicopathological features and patient survival data. Results: Nuclear SALL4 expression was observed in 39/190 HCCs (20.5%), while K19 and EpCAM were expressed in 30 (15.9%) and 92 (48.7%) HCCs, respectively. The nuclear expression was generally weak, punctate or clumped. SALL4 expression was significantly associated with a poor overall survival compared to SALL4-negative HCCs (p = .014) compared to SALL4-negative HCCs. On multivariate analysis adjusted for tumor size, multiplicity, vascular invasion, and pathological tumor stage, SALL4 remained as a significant independent predictor of decreased overall survival (p= .004). SALL4 expression was positively correlated with EpCAM expression (p = .013) but not with K19 expression. HCCs that expressed both SALL4 and EpCAM were associated with significantly decreased overall survival, compared to those cases which were negative for both of these markers (p = .031). Conclusions: Although SALL4 expression was not significantly correlated with other clinicopathological parameters suggestive of tumor aggressiveness, SALL4 expression was an independent predictor of poor overall survival in human HCCs, and was also positively correlated with EpCAM expression.
Abstract
Background: There is increasing interest in hepatocellular carcinomas (HCC) expressing “stemness”-related markers, as they have been associated with aggressive behavior and poor prognosis. In this study, we investigated the usefulness of Sal-like protein 4 (SALL4), a recently proposed candidate marker of “stemness.” Methods: Immunohistochemical stains were performed for SALL4, K19, and epithelial cellular adhesion molecule (EpCAM) on tissue microarrays constructed from 190 surgically resected HCCs, and the results were correlated with the clinicopathological features and patient survival data. Results: Nuclear SALL4 expression was observed in 39/190 HCCs (20.5%), while K19 and EpCAM were expressed in 30 (15.9%) and 92 (48.7%) HCCs, respectively. The nuclear expression was generally weak, punctate or clumped. SALL4 expression was significantly associated with a poor overall survival compared to SALL4-negative HCCs (p = .014) compared to SALL4-negative HCCs. On multivariate analysis adjusted for tumor size, multiplicity, vascular invasion, and pathological tumor stage, SALL4 remained as a significant independent predictor of decreased overall survival (p= .004). SALL4 expression was positively correlated with EpCAM expression (p = .013) but not with K19 expression. HCCs that expressed both SALL4 and EpCAM were associated with significantly decreased overall survival, compared to those cases which were negative for both of these markers (p = .031). Conclusions: Although SALL4 expression was not significantly correlated with other clinicopathological parameters suggestive of tumor aggressiveness, SALL4 expression was an independent predictor of poor overall survival in human HCCs, and was also positively correlated with EpCAM expression.
참고문헌 (21)
- Lee JS, "A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells", Nat Med, 12, pp.410~416 (2006)
- Nault JC, "A hepatocellular carcinoma 5-gene score associated with survival of patients after liver resection", Gastroenterology, 145, pp.176~187 (2013)
- Woo HG, "Identification of a cholangiocarcinoma-like gene expression trait in hepatocellular carcinoma", Cancer Res, 70, pp.3034~3041 (2010)
- Yamashita T, "EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma", Cancer Res, 68, pp.1451~1461 (2008)
- Kim H, "Human hepatocellular carcinomas with"Stemness"-related marker expression : keratin 19 expression and a poor prognosis", Hepatology, 54, pp.1707~1717 (2011)
- Kim H, "Hepatocellular carcinomas expressing ‘stemness’-related markers : clinicopathological characteristics", Dig Dis, 32, pp.778~785 (2014)
- Govaere O, "Keratin 19 : a key role player in the invasion of human hepatocellular carcinomas", Gut, 63, pp.674~685 (2014)
- Kim H, "TERT and shelterin complex proteins in hepatocellular carcinomas expressing"ste-mness"-related markers", J Hepatol, 59, pp.746~752 (2013)
- Oikawa T, "Sal-like protein 4 (SALL4), a stem cell biomarker in liver cancers", Hepatology, 57, pp.1469~1483 (2013)
- Yong KJ, "Oncofetal gene SALL4 in aggressive hepatocellular carcinoma", N Engl J Med, 368, pp.2266~2276 (2013)
- Zeng SS, "The transcription factor SALL4 regulates stemness of EpCAM-positive hepatocellular carcinoma", J Hepatol, 60, pp.127~134 (2014)
- Zhang J, "SALL4 modulates embryonic stem cell pluripotency and early embryonic development by the transcriptional regulation of Pou5f1", Nat Cell Biol, 8, pp.1114~1123 (2006)
- Wu Q, "SALL4 interacts with Nanog and co-occupies Nanog genomic sites in embryonic stem cells", J Biol Chem, 281, pp.24090~24094 (2006)
- Kohlhase J, "Okihiro syndrome is caused by SALL4 mutations", Hum Mol Genet, 11, pp.2979~2987 (2002)
- Ikeda H, "α-Fetoprotein-producing gastric carcinoma and combined hepatocellular and cholangiocarcinoma show similar morphology but different histogenesis with respect to SALL4 expression", Hum Pathol, 43, pp.1955~1963 (2012)
- Ushiku T, "SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma", Am J Surg Pathol, 34, pp.533~540 (2010)
- Ma Y, "SALL4, a novel oncogene, is constitutively expressed in human acute myeloid leukemia (AML) and induces AML in transgenic mice", Blood, 108, pp.2726~2735 (2006)
- Cao D, "SALL4 is a novel sensitive and specific marker for metastatic germ cell tumors, with particular utility in detection of metastatic yolk sac tumors", Cancer, 115, pp.2640~2651 (2009)
- Oikawa T, "SALL4 regulates cell fate decision in fetal hepatic stem", progenitor cells, 2009, pp.136, 1000~1011
- Liu TC, "SALL4 immunoreactivity predicts prognosis in Western hepatocellular carcinoma patients but is a rare event : a study of 236 cases", Am J Surg Pathol, 38, pp.966~972 (2014)
- Gonzalez-Roibon N, "Immunohistochemical expression of SALL4 in hepatocellular carcinoma, a potential pitfall in the differential diagnosis of yolk sac tumors", Hum Pathol, 44, pp.1293~1299 (2013)